McArdle Disease (Type V)
Overview
Plain-Language Overview
McArdle Disease (Type V) is a rare inherited condition that affects the muscles, specifically how they produce energy during exercise. It is caused by a deficiency of an important enzyme called myophosphorylase, which helps break down stored sugar in muscle cells to provide energy. People with this condition often experience muscle cramps, weakness, and fatigue during physical activity. A common symptom is the inability to sustain exercise, especially activities requiring quick bursts of energy. Sometimes, muscle breakdown can lead to dark urine, a sign of muscle damage. This disease primarily impacts the skeletal muscles and can significantly limit physical performance.
Clinical Definition
McArdle Disease (Type V) is a glycogen storage disorder caused by a deficiency of the enzyme myophosphorylase due to mutations in the PYGM gene. This enzyme deficiency impairs glycogenolysis in skeletal muscle, preventing the breakdown of glycogen into glucose-1-phosphate during anaerobic metabolism. As a result, affected individuals experience exercise intolerance, early muscle fatigue, and muscle cramps during strenuous activity. A hallmark feature is the second wind phenomenon, where symptoms improve after a brief rest due to increased blood flow and alternative energy substrate utilization. The disease is inherited in an autosomal recessive pattern and can lead to rhabdomyolysis with myoglobinuria in severe cases. Diagnosis is important to differentiate from other causes of muscle weakness and to guide management.
Inciting Event
Onset of symptoms typically follows anaerobic or high-intensity exercise such as sprinting or weightlifting.
Episodes may be triggered by sudden exertion after rest or warm-up.
Prolonged or repetitive muscle use without adequate aerobic metabolism precipitates symptoms.
Rarely, emotional stress or fever can exacerbate muscle symptoms.
Fasting or low carbohydrate intake may worsen exercise intolerance.
Latency Period
Symptoms usually develop within minutes of initiating intense exercise.
Patients often report a delay of weeks to months before diagnosis after symptom onset.
Initial episodes may be mild and overlooked, prolonging latency to diagnosis.
Repeated exercise exposures are needed before characteristic symptoms become apparent.
Latency from genetic mutation to clinical presentation is lifelong but asymptomatic until stress.
Diagnostic Delay
Misattribution of symptoms to muscle strain or overuse injury is common.
Lack of awareness of metabolic myopathies among clinicians delays testing.
Normal resting muscle strength and labs may falsely reassure providers.
Failure to perform forearm exercise test or muscle biopsy with enzyme assay prolongs diagnosis.
Symptoms may be attributed to psychosomatic causes or poor fitness.
Clinical Presentation
Signs & Symptoms
Exercise intolerance with early fatigue and muscle pain
Second wind phenomenon characterized by symptom improvement after brief rest during exercise
Muscle cramps and stiffness during or after physical activity
Myoglobinuria causing dark urine after intense exercise
No systemic symptoms such as fever or weight loss
History of Present Illness
Patients report exercise intolerance with early muscle fatigue and cramps during anaerobic activity.
Episodes of myalgia and muscle stiffness occur shortly after starting intense exercise.
Some describe a 'second wind' phenomenon where symptoms improve after brief rest.
Recurrent rhabdomyolysis with dark urine may occur after severe episodes.
Symptoms typically resolve with rest but recur with repeated exertion.
Past Medical History
No prior chronic muscle disease or systemic illness is typical.
History of recurrent exercise-induced muscle cramps or weakness may be present.
Absence of medication use that causes myopathy or rhabdomyolysis.
No history of endocrine or electrolyte disorders affecting muscle function.
No prior episodes of severe rhabdomyolysis requiring hospitalization unless advanced.
Family History
Positive family history of exercise intolerance or muscle cramps suggests autosomal recessive inheritance.
Siblings may have similar symptoms or confirmed diagnosis of McArdle disease.
Consanguinity increases risk of inheriting PYGM mutations.
No association with other systemic genetic syndromes.
Genetic counseling is recommended for affected families.
Physical Exam Findings
Muscle weakness predominantly in proximal muscles after exertion
Muscle cramps and tenderness during or after exercise
Normal muscle strength at rest
No muscle atrophy in early stages
Possible muscle hypertrophy due to repeated exercise
Diagnostic Workup
Diagnostic Criteria
Diagnosis of McArdle Disease is established by demonstrating deficient myophosphorylase enzyme activity in a muscle biopsy or by identifying pathogenic mutations in the PYGM gene through genetic testing. Clinical features such as exercise intolerance, early muscle fatigue, and the second wind phenomenon support the diagnosis. Elevated serum creatine kinase (CK) levels after exercise and absence of lactate rise during ischemic forearm exercise testing are also characteristic findings. Muscle biopsy may show subsarcolemmal glycogen accumulation and absent enzyme staining. Genetic testing is increasingly preferred for confirmation due to its noninvasive nature.
Pathophysiology
Key Mechanisms
Deficiency of muscle glycogen phosphorylase due to mutations in the PYGM gene impairs glycogen breakdown in skeletal muscle.
Inability to generate glucose-1-phosphate from glycogen leads to deficient ATP production during anaerobic exercise.
Accumulation of glycogen in muscle fibers causes structural disruption and muscle damage.
Reduced availability of substrate-level phosphorylation during intense exercise results in early muscle fatigue and cramps.
Compensatory reliance on oxidative phosphorylation limits exercise capacity during high-intensity activity.
| Involvement | Details |
|---|---|
| Organs | Muscular system is affected with symptoms of muscle cramps, fatigue, and weakness during anaerobic exercise. |
Liver is not primarily involved but may be relevant in differential diagnosis of glycogen storage diseases. | |
| Tissues | Skeletal muscle tissue is the primary site of pathology, showing glycogen accumulation and impaired energy metabolism leading to exercise intolerance. |
| Cells | Skeletal muscle cells are primarily affected due to deficiency of myophosphorylase, impairing glycogen breakdown and energy production during anaerobic exercise. |
| Chemical Mediators | Myophosphorylase enzyme deficiency caused by mutations in the PYGM gene leads to impaired glycogenolysis in skeletal muscle. |
Creatine kinase levels are elevated in serum during episodes of muscle injury and rhabdomyolysis. | |
Lactate production is reduced during exercise due to blocked glycogen breakdown, causing the characteristic flat lactate curve on exercise testing. |
Treatments
Pharmacological Treatments
Non-pharmacological Treatments
Regular moderate-intensity aerobic exercise to improve muscle oxidative capacity and reduce symptoms.
High-protein and high-carbohydrate diet to provide alternative energy sources and improve exercise tolerance.
Pre-exercise ingestion of simple carbohydrates to prevent muscle cramps and fatigue during activity.
Avoidance of strenuous or intense anaerobic exercise to reduce risk of rhabdomyolysis and muscle injury.
Prevention
Pharmacological Prevention
No approved pharmacological treatments to prevent symptoms
Oral creatine supplementation may improve exercise tolerance in some patients
Vitamin B6 (pyridoxine) has been tried but lacks strong evidence
Avoidance of statins and other myotoxic drugs to reduce risk of rhabdomyolysis
Non-pharmacological Prevention
Regular moderate aerobic exercise to improve muscle oxidative capacity
Avoidance of intense anaerobic exercise that triggers symptoms
Pre-exercise carbohydrate-rich diet to provide alternative energy sources
Adequate hydration to prevent rhabdomyolysis complications
Patient education on recognizing early signs of muscle injury
Outcome & Complications
Complications
Rhabdomyolysis leading to acute kidney injury
Myoglobinuria causing renal tubular damage
Permanent muscle damage from repeated severe episodes
Exercise-induced compartment syndrome in rare cases
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
McArdle Disease (Type V) versus Pompe Disease (Type II Glycogen Storage Disease)
McArdle Disease (Type V) | Pompe Disease (Type II Glycogen Storage Disease) |
|---|---|
Autosomal recessive deficiency of muscle glycogen phosphorylase | Autosomal recessive deficiency of acid alpha-glucosidase |
Adolescence or early adulthood onset with exercise intolerance and muscle cramps | Infantile or early childhood onset with cardiomegaly and hypotonia |
Elevated creatine kinase with impaired glycogen breakdown in cytoplasm | Elevated creatine kinase with increased glycogen accumulation in lysosomes |
Low myophosphorylase activity in muscle biopsy | Low acid alpha-glucosidase activity in muscle biopsy or blood |
McArdle Disease (Type V) versus Tarui Disease (Type VII Glycogen Storage Disease)
McArdle Disease (Type V) | Tarui Disease (Type VII Glycogen Storage Disease) |
|---|---|
Deficiency of muscle glycogen phosphorylase | Deficiency of phosphofructokinase in muscle |
Exercise intolerance with muscle cramps and myoglobinuria but no hemolysis | Exercise intolerance with early muscle weakness and hemolysis |
Low myophosphorylase activity in muscle biopsy | Low phosphofructokinase activity in muscle biopsy |
McArdle Disease (Type V) versus Mitochondrial Myopathy
McArdle Disease (Type V) | Mitochondrial Myopathy |
|---|---|
Autosomal recessive inheritance | Maternal inheritance with heteroplasmy |
Exercise-induced muscle cramps and fatigue without multisystem involvement | Progressive weakness with multisystem involvement including CNS and cardiac symptoms |
Normal lactate at rest, possible mild elevation after exercise | Elevated lactate and pyruvate levels at rest and after exercise |
Excess glycogen accumulation and absent or reduced myophosphorylase activity | Ragged red fibers on muscle biopsy and mitochondrial DNA mutations |
McArdle Disease (Type V) versus Carnitine Palmitoyltransferase II Deficiency
McArdle Disease (Type V) | Carnitine Palmitoyltransferase II Deficiency |
|---|---|
Symptoms triggered by brief intense exercise | Symptoms triggered by prolonged fasting or sustained exercise |
Normal acylcarnitine profile with elevated creatine kinase | Elevated long-chain acylcarnitines and hypoketotic hypoglycemia |
Reduced myophosphorylase activity in muscle biopsy | Reduced CPT II enzyme activity in muscle or fibroblasts |